Researchers at the University of Massachusetts Amherst, as part of a multi-institution research team, received $4.8 million in life science funding from the National Cancer Institute as part of a five-year life science grant to research a way to target various diseases including Alzheimer’s, cancer and graft-versus-host disease (GVHD) by changing the function of an enzyme that sets in motion over 100 different protein substrates in the body.
Read More
0 Comments Click here to read/write comments
Tags: 2014, 2013, Northeast, University of Massachusetts Amherst, Massachusetts, BioResearch Product Faire Event, MA, Amherst, cancer treatment market, UMASS, Alzheimer's treatment market